Gaëtan Ligat

495 total citations
20 papers, 317 citations indexed

About

Gaëtan Ligat is a scholar working on Epidemiology, Parasitology and Hepatology. According to data from OpenAlex, Gaëtan Ligat has authored 20 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Parasitology and 4 papers in Hepatology. Recurrent topics in Gaëtan Ligat's work include Cytomegalovirus and herpesvirus research (14 papers), Herpesvirus Infections and Treatments (10 papers) and Toxoplasma gondii Research Studies (6 papers). Gaëtan Ligat is often cited by papers focused on Cytomegalovirus and herpesvirus research (14 papers), Herpesvirus Infections and Treatments (10 papers) and Toxoplasma gondii Research Studies (6 papers). Gaëtan Ligat collaborates with scholars based in France, Morocco and United States. Gaëtan Ligat's co-authors include Sébastien Hantz, Sophie Alain, Thomas F. Baumert, Raphaël Cazal, Éloi R. Verrier, Michael Nassal, Valério Taverniti, Yannick Debing, Dieudonné Buh Kum and Mirjam B. Zeisel and has published in prestigious journals such as Nature Neuroscience, Hepatology and Scientific Reports.

In The Last Decade

Gaëtan Ligat

17 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaëtan Ligat France 11 257 102 67 58 38 20 317
Ellen H. Nagami United States 7 186 0.7× 135 1.3× 42 0.6× 57 1.0× 14 0.4× 11 283
Cyrus Badshah United States 10 273 1.1× 35 0.3× 149 2.2× 12 0.2× 30 0.8× 22 342
Clemens Jäger Germany 4 301 1.2× 148 1.5× 60 0.9× 42 0.7× 9 0.2× 4 380
Philip D. Yin United States 9 144 0.6× 121 1.2× 92 1.4× 68 1.2× 5 0.1× 14 299
Markus von Schaewen United States 10 178 0.7× 199 2.0× 51 0.8× 52 0.9× 5 0.1× 13 299
Janina Bruening Germany 8 101 0.4× 169 1.7× 108 1.6× 55 0.9× 3 0.1× 11 313
Melanie R. Walker Australia 9 109 0.4× 169 1.7× 40 0.6× 53 0.9× 3 0.1× 19 261
Corinna M. Bremer Germany 11 470 1.8× 405 4.0× 63 0.9× 68 1.2× 3 0.1× 13 552
Rumana Azad United States 4 217 0.8× 63 0.6× 48 0.7× 234 4.0× 17 0.4× 6 431

Countries citing papers authored by Gaëtan Ligat

Since Specialization
Citations

This map shows the geographic impact of Gaëtan Ligat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaëtan Ligat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaëtan Ligat more than expected).

Fields of papers citing papers by Gaëtan Ligat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaëtan Ligat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaëtan Ligat. The network helps show where Gaëtan Ligat may publish in the future.

Co-authorship network of co-authors of Gaëtan Ligat

This figure shows the co-authorship network connecting the top 25 collaborators of Gaëtan Ligat. A scholar is included among the top collaborators of Gaëtan Ligat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaëtan Ligat. Gaëtan Ligat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flores, T, et al.. (2025). Deciphering letermovir's mode of action and resistance mutation effects. Antiviral Research. 244. 106289–106289.
2.
Zahm, Margot, H Garnier, Sophie Allart, et al.. (2025). Toxoplasma gondii infection and chronic IL-1 elevation drive hippocampal DNA double-strand break signaling, leading to cognitive deficits. Nature Neuroscience. 28(10). 2067–2077.
3.
Poyet, Jean‐Luc, et al.. (2025). First evidence of efficacy of peptides targeting the pUL56-pUL89 interaction domain of the human cytomegalovirus terminase complex. Antiviral Research. 242. 106259–106259. 1 indexed citations
4.
Lefèvre, Caroline, et al.. (2025). Key domains involved in the interaction and assembly of the HCMV terminase complex. Scientific Reports. 15(1). 44943–44943.
5.
Malnou, Cécile E., et al.. (2024). Challenges and advances in the management of HCMV infections. Virologie. 28(5). 309–325. 2 indexed citations
6.
Ligat, Gaëtan, et al.. (2023). The Yin and the Yang of extracellular vesicles during viral infections. Biomedical Journal. 47(5). 100659–100659. 15 indexed citations
7.
Taverniti, Valério, Gaëtan Ligat, Yannick Debing, et al.. (2022). Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives. Journal of Clinical Medicine. 11(5). 1349–1349. 39 indexed citations
8.
Ligat, Gaëtan, Sophie Alain, & Sébastien Hantz. (2021). Towards a Prophylactic Vaccine for the Prevention of HCMV Infection. Vaccines. 9(9). 968–968. 2 indexed citations
9.
Alain, Sophie, et al.. (2021). New Insights into Human Cytomegalovirus pUL52 Structure. Viruses. 13(8). 1638–1638. 7 indexed citations
10.
Ligat, Gaëtan, Éloi R. Verrier, Michael Nassal, & Thomas F. Baumert. (2021). Hepatitis B virus–host interactions and novel targets for viral cure. Current Opinion in Virology. 49. 41–51. 27 indexed citations
12.
Ligat, Gaëtan, Kaku Goto, Éloi R. Verrier, & Thomas F. Baumert. (2020). Targeting Viral cccDNA for Cure of Chronic Hepatitis B. Current Hepatology Reports. 19(3). 235–244. 16 indexed citations
13.
Ligat, Gaëtan, et al.. (2020). Le complexe terminase, une cible de choix dans le traitement de l’infection à cytomégalovirus humain. médecine/sciences. 36(4). 367–375. 6 indexed citations
14.
Ligat, Gaëtan, et al.. (2019). Highlighting of a LAGLIDADG and a Zing Finger Motifs Located in the pUL56 Sequence Crucial for HCMV Replication. Viruses. 11(12). 1093–1093. 8 indexed citations
15.
Wrensch, Florian, Gaëtan Ligat, Laura Heydmann, et al.. (2019). Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection. Hepatology. 70(5). 1506–1520. 17 indexed citations
16.
Ligat, Gaëtan, Sandra Da Re, Sophie Alain, & Sébastien Hantz. (2018). Identification of Amino Acids Essential for Viral Replication in the HCMV Helicase-Primase Complex. Frontiers in Microbiology. 9. 2483–2483. 14 indexed citations
17.
Ligat, Gaëtan, Raphaël Cazal, Sébastien Hantz, & Sophie Alain. (2018). The human cytomegalovirus terminase complex as an antiviral target: a close-up view. FEMS Microbiology Reviews. 42(2). 137–145. 73 indexed citations
18.
Wrensch, Florian, Émilie Crouchet, Gaëtan Ligat, et al.. (2018). Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design. Frontiers in Immunology. 9. 1436–1436. 39 indexed citations
19.
Ligat, Gaëtan, et al.. (2017). Identification of a short sequence in the HCMV terminase pUL56 essential for interaction with pUL89 subunit. Scientific Reports. 7(1). 8796–8796. 18 indexed citations
20.
Mazeron, Marie‐Christine, Gaëtan Ligat, Claire Pouteil‐Noble, et al.. (2016). Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. Antiviral Research. 129. 115–119. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026